Nutra Pharma Corp Stock Price Prediction
| NPHC Stock | USD 0.0001 0.00 0.00% |
Oversold Vs Overbought
52
Oversold | Overbought |
Using Nutra Pharma hype-based prediction, you can estimate the value of Nutra Pharma Corp from the perspective of Nutra Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Nutra Pharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Nutra because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nutra Pharma after-hype prediction price | USD 9.9E-5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nutra |
Nutra Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Nutra Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nutra Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Nutra Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nutra Pharma Estimiated After-Hype Price Volatility
In the context of predicting Nutra Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nutra Pharma's historical news coverage. Nutra Pharma's after-hype downside and upside margins for the prediction period are 0.00 and 50.01, respectively. We have considered Nutra Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nutra Pharma is out of control at this time. Analysis and calculation of next after-hype price of Nutra Pharma Corp is based on 3 months time horizon.
Nutra Pharma Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nutra Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nutra Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nutra Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
192.86 | 439.34 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.000099 | 0.52 |
|
Nutra Pharma Hype Timeline
Nutra Pharma Corp is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Nutra is forecasted to decline in value after the next headline, with the price expected to drop to 9.9E-5. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -0.52%, whereas the daily expected return is now at 192.86%. The volatility of related hype on Nutra Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company had not issued any dividends in recent years. Nutra Pharma Corp had 1:40 split on the 18th of May 2015. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.Nutra Pharma Related Hype Analysis
Having access to credible news sources related to Nutra Pharma's direct competition is more important than ever and may enhance your ability to predict Nutra Pharma's future price movements. Getting to know how Nutra Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nutra Pharma may potentially react to the hype associated with one of its peers.
Nutra Pharma Additional Predictive Modules
Most predictive techniques to examine Nutra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nutra using various technical indicators. When you analyze Nutra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nutra Pharma Predictive Indicators
The successful prediction of Nutra Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nutra Pharma Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nutra Pharma based on analysis of Nutra Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nutra Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nutra Pharma's related companies.
Story Coverage note for Nutra Pharma
The number of cover stories for Nutra Pharma depends on current market conditions and Nutra Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nutra Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nutra Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Nutra Pharma Short Properties
Nutra Pharma's future price predictability will typically decrease when Nutra Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nutra Pharma Corp often depends not only on the future outlook of the potential Nutra Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nutra Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.6 B | |
| Cash And Short Term Investments | 90.9 K |
Complementary Tools for Nutra Pink Sheet analysis
When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |